These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16820880)

  • 1. Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target.
    Shimokawa T; Matsushima S; Tsunoda T; Tahara H; Nakamura Y; Furukawa Y
    Int J Oncol; 2006 Aug; 29(2):381-6. PubMed ID: 16820880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells.
    Obama K; Kato T; Hasegawa S; Satoh S; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2006 Jan; 12(1):70-6. PubMed ID: 16397026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.
    Yuki D; Lin YM; Fujii Y; Nakamura Y; Furukawa Y
    Oncol Rep; 2004 Aug; 12(2):275-80. PubMed ID: 15254688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
    Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H
    Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
    Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
    Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRF-1 is the major transcription factor regulating the expression of the human TOMM34 gene.
    Blesa JR; Prieto-Ruiz JA; Abraham BA; Harrison BL; Hegde AA; Hernández-Yago J
    Biochem Cell Biol; 2008 Feb; 86(1):46-56. PubMed ID: 18364745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor.
    Sakai M; Shimokawa T; Kobayashi T; Matsushima S; Yamada Y; Nakamura Y; Furukawa Y
    Oncogene; 2006 Jan; 25(3):480-6. PubMed ID: 16170351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR signaling pathway is a target for the treatment of colorectal cancer.
    Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
    Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.
    Takahashi K; Furukawa C; Takano A; Ishikawa N; Kato T; Hayama S; Suzuki C; Yasui W; Inai K; Sone S; Ito T; Nishimura H; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2006 Oct; 66(19):9408-19. PubMed ID: 17018595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorting nexin 1 down-regulation promotes colon tumorigenesis.
    Nguyen LN; Holdren MS; Nguyen AP; Furuya MH; Bianchini M; Levy E; Mordoh J; Liu A; Guncay GD; Campbell JS; Parks WT
    Clin Cancer Res; 2006 Dec; 12(23):6952-9. PubMed ID: 17145813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.